Trial intelligence / Profile preview

APROVE: Irbesartan Dosage Adjustment in Hypertension

NCT00564187Phase 4Completed

Sponsor
Sanofi
Start
Feb 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of irbesartan in hypertension (HTN), sponsored by Sanofi. Started Feb 2003; status: completed.

02

Drugs

irbesartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00564187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00564187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call